Meeting NewsVideo
American Academy of Ophthalmology Meeting

VIDEO: Leber hereditary optic neuropathy gene therapy shows positive results

January 9, 2019

CHICAGO — Mark L. Moster, MD, of Wills Eye Hospital, discusses results of the REVERSE clinical trial, which is evaluating the efficacy of GS010 (GenSight Biologics) to treat Leber hereditary optic neuropathy, at the American Academy of Ophthalmology meeting.

CHICAGO — Mark L. Moster, MD, of Wills Eye Hospital, discusses results of the REVERSE clinical trial, which is evaluating the efficacy of GS010 (GenSight Biologics) to treat Leber hereditary optic neuropathy, at the American Academy of Ophthalmology meeting.

    See more from American Academy of Ophthalmology Meeting